TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to 25c from 90c and keeps a Hold rating on the shares. The firm updated its model to reflect 3Q24 results. The model assumes the company requires a $100m capital raise in 2025 to support continued operating losses.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PIII:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue